Mainstream

Astellas Pharma Non Gaap Eps Of ¥124.60, Revenue Of ¥1453.03b; Updates Fy Outlook

Astellas Pharma Non-GAAP EPS of ¥124.60, revenue of ¥1453.03B; updates FY outlook

Astellas Pharma Non-GAAP EPS of ¥124.60, revenue of ¥1453.03B; updates FY outlook

Post Contentalpmf, alpmyRead More

You might also be interested in reading Bayer MRI contrast agent gadoquatrane meets goals in phase 3 trials.

February 4, 2025
In Mainstream